Clinical Trial Update: The Effect of Sulfasalazine on CRH Levels in Pregnant Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether sulfasalazine affects CRH levels in pregnant women to address risk of preterm birth; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Preterm Birth | Phase 2 | Status: RECRUITING